Morning Briefing
Summaries of health policy coverage from major news organizations
Hepatitis C Drug Fuels Cost Debate
A panel of experts said this week that the drug represents a "low value" to the health system because of its cost.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
